This increase in unspecifically activated cytokine producing T cells upon blocking TNF possibly represents some kind of ‘compensatory immunological switch’, which might contribute to the induction or exacerbation of secondary autoimmune phenomena, such as systemic lupus erythematosus or psoriasis, in TNFi treated patients [47]. The gene discussed is TNF; the disease is psoriasis.